NCT06061861

Brief Summary

The goal of this randomized controlled trial is to compare the effect of receiving 6 months of monetary support for healthy food through a food delivery platform on change in glycosylated hemoglobin (HbA1c) levels among adults with type 2 diabetes mellitus with glycemic control that is above target level. The main study aims are to:

  1. 1.To evaluate whether providing monthly financial support for home-delivered healthy food vs. only free food delivery through the Instacart platform reduces glycosylated hemoglobin levels within 6 months among Medi-Cal-insured Kaiser Permanente adult members with diabetes mellitus and suboptimal glycemic control.
  2. 2.To evaluate whether providing monthly financial support for home-delivered healthy food vs. only free food delivery through the Instacart platform reduces medical resource utilization within 6 months among Medi-Cal-insured Kaiser Permanente adult members with diabetes mellitus and suboptimal glycemic control.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,007

participants targeted

Target at P75+ for not_applicable diabetes-mellitus-type-2

Timeline
0mo left

Started Oct 2023

Typical duration for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Oct 2023Jun 2026

First Submitted

Initial submission to the registry

September 12, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 29, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 27, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

January 8, 2026

Status Verified

December 1, 2025

Enrollment Period

2.2 years

First QC Date

September 12, 2023

Last Update Submit

January 6, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • 6-month change in glycosylated hemoglobin level

    Baseline glycosylated hemoglobin will be ascertained using routine laboratory tests in the electronic health record prior to enrollment. Participants will complete glycosylated hemoglobin testing 6 months after enrollment.

    6 months after enrollment

Secondary Outcomes (8)

  • 12-month change in glycosylated hemoglobin level

    12 months after enrollment

  • Percentage of participants with glycosylated hemoglobin <7.5%

    6- and 12-months after enrollment

  • All-cause hospitalizations or emergency department visits

    3-, 6-, and 12-months after enrollment

  • Change in self-reported level of food security

    6- and 12-months after enrollment

  • Change in self-reported level of nutrition security

    6- and 12-months after enrollment

  • +3 more secondary outcomes

Study Arms (2)

Financial Support and Free Delivery

EXPERIMENTAL

The intervention group will receive monthly financial support for healthy food items along with free home delivery through the Instacart platform.

Other: Financial support for healthy foods and free home delivery

Free Delivery

EXPERIMENTAL

The control group will receive only free home delivery through the Instacart platform.

Other: Free home delivery

Interventions

Participants will have home delivery and service fees waived for 4 orders per month through the Instacart platform for a duration of 6 months.

Free Delivery

Participants will receive monetary support to spend on healthy food items (e.g., vegetables and fruit) through the Instacart platform for a duration of 6 months and have home delivery and service fees waived for 4 orders per month through the Instacart platform for a duration of 6 months.

Financial Support and Free Delivery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged ≥18 years old at enrollment
  • Active membership in Kaiser Permanente with Medi-Cal insurance and no additional private or commercial insurance
  • Diagnosis of Type II diabetes mellitus (not including Type I diabetes mellitus or gestational diabetes mellitus)
  • At least 2 outpatient glycosylated hemoglobin measures ≥7.5% in the prior 18 months
  • Current access to the internet via computer or mobile device
  • No interpreter needed

You may not qualify if:

  • Advanced or end-stage kidney disease (estimated glomerular filtration rate ≤15 ml/min/1.73m\^2 or receiving outpatient dialysis or having a prior kidney transplant)
  • Known pregnancy at time of identification

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kaiser Permanente Southern California Department of Research & Evaluation

Pasadena, California, 91101, United States

Location

Kaiser Permanente Northern California Division of Research

Pleasanton, California, 94588, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Financial Support

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

EconomicsHealth Care Economics and Organizations

Study Officials

  • Claudia L Nau, PhD

    Kaiser Permanente

    PRINCIPAL INVESTIGATOR
  • Richard Grant, MD, MPH

    Kaiser Permanente

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2023

First Posted

September 29, 2023

Study Start

October 1, 2023

Primary Completion

December 27, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

January 8, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations